How to Buy Canopy Growth Stock (CGC)

How to invest in Canopy Growth Stock

To buy shares of Canopy Growth, you need a brokerage account. If you don't have one yet, take a look at our favorite brokers and trading platforms to find the right one for you.

1. Open your brokerage app: Log in to your brokerage account where you handle your investments.
2. Fund your account: Transfer money so you’re ready to invest.
3. Search for Canopy Growth: Enter the ticker symbol "CGC" into the search bar to bring up Canopy Growth's trading page.
4. Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to Canopy Growth.
5. Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
6. Submit your order: Confirm the details and submit your buy order.
7. Review your purchase: Check your portfolio to ensure your order was filled as expected. And that's it! Quick and easy.

Should you invest in Canopy Growth?

Canopy Growth continues to struggle financially. In fiscal 2025 (ended March 31), revenue fell 9% to CA$269 million, and the company posted a GAAP loss of CA$598 million, largely driven by fair-value losses tied to its Canopy USA investment. That said, adjusted EBITDA losses narrowed 60% to CA$23.5 million as cost cuts, a shift toward higher-margin medical sales, and fewer inventory write-downs improved gross margin by 300 basis points.

The company has scaled back aggressively. In 2023, it exited Canadian retail by selling or closing dozens of stores, underscoring intense competition and weak economics in that market. Today, Canopy operates across Canadian cannabis, international cannabis, and Storz & Bickel, its vaporizer business, while maintaining U.S. exposure through Canopy USA and brands like Acreage, Wana, and Jetty.

Despite some operational improvements, Canopy remains unprofitable. Its sharply reduced market cap, about CA$317 million, reflects those challenges. Investors may want to wait for clearer evidence of sustainable profitability before considering the stock.

Is Canopy Growth profitable?

Canopy Growth has never reported a GAAP operating profit and remains unprofitable despite significant restructuring. The company has sold noncore assets, including its retail operations and the This Works skin care brand, and has focused on cutting costs and reducing debt.

Those efforts have improved the balance sheet but not the bottom line. In fiscal 2025, Canopy cut debt from roughly CA$600 million to about CA$300 million through prepayments and a debt-to-equity exchange with a Constellation Brands affiliate. Even so, high interest expense of CA$105 million continues to weigh on results, and earnings remain volatile due to minority investments, impairments, and restructuring charges.

Operational performance is still weak. Only one of Canopy’s three main segments posted revenue growth in the most recent quarter, with Canada cannabis sales rising just 4%. For fiscal 2025, the company reported a GAAP operating loss of CA$117 million, an adjusted EBITDA loss of CA$23.5 million, and negative operating cash flow of CA$282 million.

Lower debt improves Canopy’s odds of eventually turning profitable, but without clearer growth drivers or sustained margin expansion, profitability remains a distant goal.

Does Canopy Growth pay a dividend?

Canopy Growth does not pay a dividend. According to the company's annual report, it has no intention of declaring dividends on Canopy shares in the foreseeable future.

Unprofitable companies generally do not pay dividends since they are unable to fund dividend payments from the business. Additionally, companies that pay dividends tend to be more mature, slower-growth businesses.

For those reasons, it's unlikely that Canopy Growth will pay a dividend soon, if ever.

Will Canopy Growth's stock split?

Stock splits tend to happen after a stock has made significant gains and its share price is much higher than it was earlier.

That might have been the case for Canopy Growth when the stock skyrocketed twice before. But the share price has fallen to almost $1 a share, and the company had a reverse stock split in December 2023. It could be forced to do one again since the Nasdaq Stock Exchange generally requires stocks to trade for at least $1.

Stock splits typically happen when a share price is more than $100, if not significantly higher. Without measurable gains, there's no reason to expect a stock split from Canopy Growth, although another reverse stock split is possible.

The bottom line

At this point, there's little doubt that Canopy Growth has had a challenging history and that its earlier growth potential has gone unfulfilled.

Based on the company's current financial performance, its trajectory, and its history of poor acquisitions and strategic errors, it seems hard to bet on a comeback for Canopy Growth, although new CEO Luc Mongeau has made a number of changes, including lowering the debt burden, unifying its medical cannabis businesses globally, streamlining its product portfolio, and cutting costs.

However, the cannabis sector can change rapidly when regulations are lifted, and Canopy stock could be invigorated if cannabis is legalized at the U.S. federal level. The Biden administration unsuccessfully pushed to have cannabis reclassified so it's considered less dangerous.

The industry remains highly competitive, so Canopy would face similar challenges in the U.S. to those it experienced in the Canadian market. It's worth watching any developments at the U.S. federal level for Canopy Growth shareholders or anyone considering buying the stock.

FAQ